DV
Dividend Vision

XNCR — Xencor Inc

Xencor Inc (XNCR)

Total return is 179.9% over the past 12.7 years, 256.1 points behind SPY at 436.0%. Its deepest 1-year drawdown was 42.6%.

Xencor Inc is a single-stock equity holding that represents shares in a biotechnology company focused on antibody and protein therapeutics. The holding does not currently pay distributions and carries no disclosed expense ratio, as it is an individual stock rather than a diversified fund. This security appeals primarily to growth-oriented investors seeking exposure to the biotechnology sector rather than to income-focused dividend investors.

XNCR key facts

Asset type
Stock
Asset class
Equity
Inception date
12/03/2013
Last close
$23.34
Market cap
$1,394,603,520
Average volume
443070.0
Beta
0.863
Payout ratio
0.0
Forward P/E
68.0272
EPS
$-2.46